photo credit: KOS Chiropractic Integrative Health / Pexels

Key Takeaways

• Brain energy metabolism can become an important consideration in some seizure disorders, particularly when treatment decisions involve metabolic therapies.
• Ketogenic diet therapy changes the brain’s available fuel sources by reducing carbohydrate intake and promoting the production of ketone bodies.
• Glucose transporter type 1 deficiency syndrome illustrates how an underlying problem with glucose delivery to the brain can create a specific rationale for ketogenic therapy.
• Ketogenic therapy requires medical supervision because treatment can affect nutrition, blood chemistry, medications, kidney-stone risk, and other aspects of health.
• The potential role of metabolic therapy depends on the specific seizure disorder, diagnosis, previous treatment response, and individual safety considerations.

Dominic D’Agostino is a tenured Associate Professor at the University of South Florida (USF) Morsani College of Medicine, where he teaches medical neuroscience, medical physiology, nutrition, and neuropharmacology. He also serves as a Senior Visiting Research Scientist at the Institute for Human and Machine Cognition (IHMC), supporting efforts to optimize the safety, health, and resilience of warfighters and astronauts. D’Agostino’s laboratory develops ketone technologies and metabolic therapies, focusing on research areas such as KetoNutrition, ketone supplementation, and cellular-level studies using electrophysiology and biochemical assays. His work spans topics including nutritional ketosis, cancer-specific glycolytic metabolism, and biomarkers related to type 2 diabetes and insulin resistance.

D’Agostino is a member of the American Physiological Society and the Undersea and Hyperbaric Medical Society, and his research into brain energy metabolism directly informs how clinicians think about seizure disorders and dietary therapy.

People often describe seizures as changes in normal brain activity. That explanation helps, but it does not settle every treatment question. Some seizure disorders raise an energy-supply question: whether the brain receives or uses enough fuel to support normal cell work. That question matters most when a diagnosis or treatment plan points to metabolism.

A seizure disrupts normal brain activity. Epilepsy involves repeated seizures, but seizure disorders can differ. They can differ by cause, starting point, spread, and symptoms. Those differences matter because one seizure explanation cannot guide every treatment discussion.

The brain needs a steady energy supply to keep cells working and signals moving. Metabolism means how the body produces and uses energy. Glucose is one major fuel the blood delivers to the brain.

When carbohydrate intake stays very low, the liver can make ketone bodies, and the brain can use those ketones as another fuel source. That fuel pathway explains why clinicians sometimes include ketogenic diet therapy in epilepsy treatment planning.

Ketogenic diet therapy is a medical nutrition treatment that limits carbohydrate intake and increases fat intake, thereby promoting the production of ketone bodies. The goal is nutritional ketosis, a metabolic state in which ketones become a major energy source. This differs from casual low-carb eating because trained medical teams prescribe, adjust, and monitor it for seizure-treatment goals.

Treatment planning becomes more complex when appropriate medicines do not control seizures. Many people with epilepsy respond to antiseizure drugs, but some continue to have seizures after suitable medication plans. In those cases, clinicians may evaluate other options, including surgery, implanted devices, or dietary therapy.

Glucose transporter type 1 deficiency syndrome clearly illustrates the brain-energy issue. In this genetic condition, the GLUT1 protein cannot move enough glucose from the blood into the brain. Nerve cells then face an energy supply problem, even when blood glucose is normal.

Ketogenic therapy can provide ketone bodies as supplemental fuel, so the treatment logic connects directly to the condition’s mechanism. Ketogenic therapy does not carry the same role across all seizure disorders. In GLUT1 deficiency, the known energy pathway gives clinicians a strong reason to consider ketogenic diet therapy as targeted treatment.

In broader epilepsy care, the decision depends on seizure type, diagnosis, prior treatment response, medical history, safety concerns, and the patient’s or family’s ability to manage structured follow-up.

Because the therapy changes metabolism, care teams monitor more than seizure counts. They may track weight, growth in children, nutritional adequacy, blood chemistry, lipid levels, electrolytes, side effects, and kidney-stone risk.

Medication review also matters because some drugs or formulations can interfere with ketosis or increase risk in specific patients. This prevents the mistaken idea that a food-based therapy is automatically simple or risk-free.

Researchers also study measurable signs that show whether ketogenic therapy lines up with seizure outcomes. Studies may compare seizure reduction with ketone levels, glucose patterns, circulating metabolites, and changes in the gut microbiome.

Those measurements do not prove benefit on their own. They help researchers ask whether metabolic changes align with seizure improvement, not just whether ketone levels rise.

The clinical question is not whether every seizure disorder has a metabolic answer, but when fuel use changes the treatment discussion enough to justify a monitored therapy. That decision depends on diagnosis, seizure pattern, prior treatment response, and safety factors that clinicians can track over time.

Keeping that boundary clear separates supervised metabolic treatment from general diet trends and keeps the focus on evidence-based seizure care.

FAQs

Why does brain energy matter in seizure disorders?

The brain requires a steady supply of energy to maintain cellular function and communication between nerve cells. In some seizure disorders, understanding how the brain obtains and uses fuel can influence treatment discussions, particularly when metabolic therapy is being considered.

What is ketogenic diet therapy?

Ketogenic diet therapy is a medical nutrition treatment that substantially limits carbohydrates and increases fat intake to promote nutritional ketosis. Unlike a general low-carbohydrate diet, it is typically prescribed and monitored by a healthcare team for specific therapeutic goals.

Why is ketogenic therapy relevant to GLUT1 deficiency?

GLUT1 deficiency syndrome affects the ability of the GLUT1 protein to transport enough glucose from the blood into the brain. Ketones can provide an alternative fuel source for the brain, creating a direct metabolic rationale for ketogenic therapy in this condition.

Is ketogenic therapy appropriate for every seizure disorder?

No, the potential role of ketogenic therapy depends on the specific diagnosis, seizure pattern, previous treatment response, medical history, and safety considerations. Some people with difficult-to-control seizures may be evaluated for dietary therapy alongside other options such as surgery or implanted devices.

What is monitored during ketogenic therapy?

Healthcare teams may monitor seizure frequency along with factors such as weight, growth, nutritional adequacy, blood chemistry, lipid levels, electrolytes, side effects, and kidney-stone risk. Medication choices and formulations may also need review because some can affect ketosis or create additional risks for certain patients.

About Dominic D’Agostino

Dominic D’Agostino is a tenured Associate Professor at the University of South Florida Morsani College of Medicine, where he teaches medical neuroscience, physiology, nutrition, and neuropharmacology. He also serves as a Senior Visiting Research Scientist at the Institute for Human and Machine Cognition in Florida. D’Agostino develops ketone technologies and metabolic therapies and is a member of the American Physiological Society and the Undersea and Hyperbaric Medical Society.